Illinois scientists are invited to attend this one-hour seminar featuring Zachary Morris, associate professor and vice-chair of the Department of Human Oncology at the University of Wisconsin-Madison. Morris will discuss how radiation can damage tumors in a way that renders them more responsive to immunotherapies. This can be used clinically to activate a focal in situ vaccine response, however, conventional external beam radiation therapy typically cannot treat all tumor sites in patients with metastatic disease because of toxicities and the inability to target small tumors that are not identified on imaging scans. Targeted radionuclide therapies preferentially deliver radiation to tumors following intravenous administration and may provide an effective way to modify the susceptibility of tumors to immune response, thereby augmenting response to immunotherapies in patients with metastatic cancers.
To request a Zoom link, click here.